Baidu (BIDU)

Baidu slipped 2.2% in premarket action after the search
engine company was added to the SEC’s list of US-traded China stocks that could
be delisted if American regulators do not get a chance to review three years’
worth of financial audits.

Novavax (NVAX)

The drug maker’s shares lost 1.3% in premarket action
after it asked European Union (EU) regulators to approve its Covid-19 vaccine
for use in teenagers.

Also Read | Ukraines’ economy to shrink by 20%, Russias’ by 10% in 2022: Report

Walgreens (WBA)

The drug store operator’s shares initially surged in the
premarket trading but lost the gains soon and dipped negative. Walgreens
reported an adjusted quarterly profit of $1.59 per share, 19 cents higher than
estimates, with revenue also beating Wall Street forecasts. Comparable pharmacy
sales rose 7.3%, helped by demand for Covid vaccines.

Also Read | Crude oil prices fall as Joe Biden considers releasing massive oil reserves

Advanced Micro Devices (AMD)

AMD shares slipped 2.2% in premarket trading. Barclays
downgraded Advanced Micro Devices to “equal weight” from “overweight,” which
points to cyclical risk in several different end markets for the semiconductor
maker.

Also Read | ‘Deeply disappointing’: United States slams India ahead of Russian FM Sergei Lavrov’s visit

HP Inc. (HPQ)

HP fell 4.5% in premarket trading after Morgan Stanley
downgraded computer equipment makers, predicting that the company will shift
spending away from hardware due to macroeconomic uncertainty. HP was downgraded
to “underweight” from “equal-weight.” Morgan Stanley downgraded Dell
Technologies to “equal-weight” from “overweight”. Dell lost 2.6% in premarket
action.

Also Read | US official says India faces ‘great risk’ if Russian oil imports grow: Report

Amylyx Pharmaceuticals (AMLX)

Amylyx shares jumped 2.5% in premarket. A panel of FDA
officials voted against recommending Amylyx’s experimental ALS drug for
approval. According to the panel, study data failed to show that the drug was
effective in fighting the disease.

Expensify (EXFY)

Expensify plunged 14.3% in the premarket action after the
online expense management firm reported a lower-than-expected quarterly profit
and released a weaker-than-expected revenue forecast for the present quarter.

Also Read | China’s Xi Jinping strongly backs Afghanistan at regional conference

Robinhood Markets (HOOD)

Robinhood won a favourable ruling in a Massachusetts
case, with a judge determining that the state overstepped its authority by
imposing a new fiduciary standard for brokerage firms in the state. The
brokerage firm was accused by regulators of encouraging its customers to take
excessive risks.

Kinross Gold (KGC)

The gold mining company is in discussions to sell a
Russian mine to Russia-backed investment firm Fortiana Holdings, reported The
Wall Street Journal. The sale would mark the first time a Western company has
sold an asset left behind in Russia.